A Simplified Low-Dose 10-Day Quadruple Therapy with a Galenic Formulation of Bismuth Salicylate Is Highly Effective for
Helicobacter pylori infection
bismuth salicylate
quadruple therapy
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
15 Jan 2023
15 Jan 2023
Historique:
received:
07
12
2022
revised:
11
01
2023
accepted:
13
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
Earlier studies have shown that a modified low-dose bismuth quadruple therapy given for 10 to 14 days is highly effective for the treatment of We aimed to investigate the efficacy of a simplified low-dose 10-day quadruple therapy containing a galenic formulation of bismuth salicylate for Adult patients positive for In this open-label pilot study, 42 patients were enrolled (mean age 54.1 ± 12.0 years; 64% female). Among the study participants, 35 were naïve to The modified low-dose 10-day quadruple therapy provided high eradication rates of
Sections du résumé
BACKGROUND
BACKGROUND
Earlier studies have shown that a modified low-dose bismuth quadruple therapy given for 10 to 14 days is highly effective for the treatment of
AIM
OBJECTIVE
We aimed to investigate the efficacy of a simplified low-dose 10-day quadruple therapy containing a galenic formulation of bismuth salicylate for
PATIENTS AND METHODS
METHODS
Adult patients positive for
RESULTS
RESULTS
In this open-label pilot study, 42 patients were enrolled (mean age 54.1 ± 12.0 years; 64% female). Among the study participants, 35 were naïve to
CONCLUSIONS
CONCLUSIONS
The modified low-dose 10-day quadruple therapy provided high eradication rates of
Identifiants
pubmed: 36675610
pii: jcm12020681
doi: 10.3390/jcm12020681
pmc: PMC9861798
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Gut. 2017 Dec;66(12):2043-2046
pubmed: 28935677
Helicobacter. 2011 Aug;16(4):295-300
pubmed: 21762269
Gut. 2021 Oct;70(10):1815-1822
pubmed: 33837118
Helicobacter. 2018 Sep;23 Suppl 1:e12519
pubmed: 30203585
FEMS Immunol Med Microbiol. 2007 Jul;50(2):249-56
pubmed: 17521391
Cleve Clin J Med. 2017 Apr;84(4):310-318
pubmed: 28388387
Gut. 2017 Jan;66(1):6-30
pubmed: 27707777
Am J Gastroenterol. 2022 Apr 1;117(4):524-528
pubmed: 35081545
Gut. 2022 Mar;71(3):643-650
pubmed: 34750206
Helicobacter. 2005;10 Suppl 1:1-4
pubmed: 16178964
Helicobacter. 1999 Jun;4(2):106-12
pubmed: 10382124
Aliment Pharmacol Ther. 1998 Jul;12(7):635-9
pubmed: 9701526
Clin Gastroenterol Hepatol. 2022 May;20(5):973-983.e1
pubmed: 33775895
Am J Gastroenterol. 2003 Mar;98(3):562-7
pubmed: 12650788
Aliment Pharmacol Ther. 2012 Sep;36(5):414-25
pubmed: 22803691
Helicobacter. 2019 Apr;24(2):e12570
pubmed: 30767339
Med J Aust. 1989 Oct 16;151(8):431-5
pubmed: 2687668
Medicine (Baltimore). 2018 Jan;97(4):e9734
pubmed: 29369216
Am J Gastroenterol. 2002 Apr;97(4):857-60
pubmed: 12003419
Open Forum Infect Dis. 2022 Apr 08;9(6):ofac165
pubmed: 35755772
Med J Aust. 1990 Aug 6;153(3):145-9
pubmed: 1974027
J Clin Gastroenterol. 1996 Jun;22(4):313-6
pubmed: 8771431
Open Forum Infect Dis. 2022 Aug 11;9(8):ofac413
pubmed: 36004310
Annu Rev Med. 2022 Jan 27;73:183-195
pubmed: 35084993
Gastroenterol Clin North Am. 2015 Sep;44(3):537-63
pubmed: 26314667